Searched for
PFIZER ADJUSTED EPS
US stock market crashes today: Why Nasdaq, S&P 500 and Dow Jones all turned red – Gold and silver surge as investors rotate into safety- Why is PFE stock falling today despite beating Pfizer's earnings estimates? Key factors investors are watching
- PFE stock rises 5.3% today: Pfizer seals Trump drug price deal with $70 billion U.S. investment and $7.3 billion Metsera weight-loss acquisition
- Pfizer stock soars as earnings smash expectations, and company raises outlookPFE stock: Pfizer's stock surged following a report of stronger-than-expected earnings, driven by robust sales of COVID-19 products and key...05 Aug, 2025, 05.59 PM IST
- Pfizer exceeds Q4 earnings estimates as covid product sales outperform expectationsStrong Covid product sales and cost-cutting initiatives drove Pfizer's $17.76 billion in revenue in Q4, exceeding Wall Street's projections...04 Feb, 2025, 07.58 PM IST
- Windlas Biotech offers its shares at 64x PE. Should you subscribe?The Dehradun-based firm will raise Rs 165 crore through issuance of fresh equity shares, while the promoters and existing shareholders will...04 Aug, 2021, 08.44 AM IST
- Buy Pfizer, target price Rs 4,705: ICICI SecuritiesThe brokerage believes that the difference between primary and secondary sales would normalise in the coming quarters. However, revenue wou...16 Jun, 2020, 02.45 PM IST
- 10 stocks that saw target price revision, re-rating post Q2 nosBrokerage Sharekhan said Sensex companies posted 8.1 per cent year-on-year profit growth.30 Nov, 2017, 10.36 AM IST
- Pfizer surges 5% as parent acquires Medivation in $14 bn dealThe US-based company said the acquisition would be immediately accretive to adjusted diluted EPS upon closing of the deal.23 Aug, 2016, 11.08 AM IST
- GlaxoSmithKline's CEO Andrew Witty backs India's pharma policy, cautious on acquisitions"I think it is wholly reasonable for a country that is having a tremendous growth with challenges has to think about pricing," Witty said.18 Nov, 2013, 06.46 AM IST
- Pfizer 4Q profit beats views as revenue up 6 pcPfizer Inc.'s new CEO on Tuesday outlined plans to reduce the company's spending and work force and focus more sharply on promising drugs a...02 Feb, 2011, 10.42 AM IST
- Edelweiss Securities puts 'buy' on Aurobindo PharmaRevenues are expected to grow at a CAGR of 20% over FY09-11E to Rs 4,400 crore, backed by high growth in the US formulations sales and pote...22 Oct, 2009, 05.27 AM IST
Load More
